Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Monitoring Cellular Interactions Using Nanotechnology

7/27/2011

Jeffrey Karp, Ph.D., Co-Director, Center for Regenerative Therapeutics; Associate Bioengineer, Brigham and Women’s Hospital; and Assistant Professor, Harvard Medical School

Using nanotechnology to engineer sensors onto the surface of cells, researchers at Brigham and Women’s Hospital have developed a platform technology for monitoring single-cell interactions in real-time. The scientists believe that this innovation addresses needs in both science and medicine by providing the ability to further understand complex cell biology, track transplanted cells, and develop effective therapeutics.


During this week’s podcast Dr. Jeffrey Karp provides additional details on this novel system for monitoring cellular interactions. Dr. Karp, who was recognized by the Boston Business Journal as a Champion in Healthcare Innovation, also discusses how currently used cell-signaling sensors operate and describes the advantages of his team’s new approach.

Jeffrey M. Karp is an assistant professor at Harvard Medical School and is co-director of the Center for Regenerative Therapeutics at the Brigham and Women's Hospital. He also holds appointments at the Harvard Stem Cell Institute and MIT. He obtained his Ph.D. from the University of Toronto. His research currently spans stem cell engineering, biomaterials, and medical devices. Dr. Karp has published more than 50 peer-reviewed papers, 15 book chapters, 60 abstracts, and has 25 issued or pending patents. He currently serves as the biology and medicine section editor for Journal Nanotechnology.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll